Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Item
http://www.wikidata.org/entity/Q37321859
A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhoDevelopment of a method based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry for studying the in vitro metabolism of phosphorothioate oligonucleotides.A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerFirst-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.Novel antisense oligonucleotides containing hydroxamate linkages: targeted iron-triggered chemical nucleases.Therapeutic nucleic acids: current clinical status.Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis.Antisense oligonucleotides in neurological disorders.A Dominant Negative Antisense Approach Targeting β-Catenin.
P2860

Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Item
http://www.wikidata.org/entity/Q37321859
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in antisense oligonuc ...... on, and as novel therapeutics.
@en
Advances in antisense oligonuc ...... on, and as novel therapeutics.
@nl
type
label
Advances in antisense oligonuc ...... on, and as novel therapeutics.
@en
Advances in antisense oligonuc ...... on, and as novel therapeutics.
@nl
prefLabel
Advances in antisense oligonuc ...... on, and as novel therapeutics.
@en
Advances in antisense oligonuc ...... on, and as novel therapeutics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P698
P932
P356
P1433
P1476
Advances in antisense oligonuc ...... ion, and as novel therapeutics
@en
P2093
P2860
P304
P31
P356
P478
P577
P698
P932